Inventor
Marc D. Feldman
Inventor
San Antonio, TX, US
Overview
Patents· 42 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Bprimary
A61BDiagnosis44%
A61NElectrotherapy14%
A61KPreparations for medical, dental or toiletry purposes6%
A61MDevices for introducing media into, or onto, the body5%
G01BMeasuring length, thickness or similar linear dimensions5%
G01NInvestigating or analysing materials by determining their chemical or physical properties5%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations4%
A61FFilters implantable into blood vessels3%
B82YSpecific uses or applications of nanostructures3%
C07KPeptides3%
PatentTitleYear
11,009,465Apparatus and methods for endometrial tissue identification202110,663,403Apparatus and methods for endometrial tissue identification202010,535,044Authentication of transactions in a network202010,512,482System and method for scoring the left ventricular endocardium to increase left ventricular compliance201910,495,440Apparatus and methods for optical coherence tomography and two-photon luminescence imaging201910,433,861System and method for cutting trabeculae carneae of the left ventricle to increase LV compliance201910,420,952Method and apparatus for treating a patient's heart using hemodynamics201910,376,177Low power apparatus and method to measure complex electrical admittance or impedance201910,368,776Method and apparatus for determining cardiac performance in a patient with a conductance catheter201910,076,669Admittance measurement for tuning bi-ventricular pacemakers20189,820,674'Method and apparatus for determining cardiac performance in a patient with a conductance catheter'20179,820,673'Method and apparatus for monitoring an organ of a patient'20179,633,277'Apparatus and methods for identifying and evaluating bright spot indications observed through optical coherence tomography'20179,532,718'Hemoglobin contrast in ultrasound and optical coherence tomography for diagnosing diseased tissue, cancers, and the like'20179,526,425'OCT using spectrally resolved bandwidth'20169,482,513'Apparatus and methods for optical coherence tomography and two-photon luminescence imaging'20169,380,946'Method and apparatus for determining cardiac performance in a patient with a conductance catheter'20169,308,254'Method for treatment of post operative cognitive dysfunction'20169,295,404'Low power apparatus and method to measure complex electrical admittance or impedance'20169,204,802'Hemoglobin contrast in ultrasound and optical coherence tomography for diagnosing diseased tissue, cancers, and the like'20158,996,099'Catheter imaging probe and method'20158,989,849'Rotating optical catheter tip for optical coherence tomography'20158,929,976'Method and apparatus for determining cardiac performance in a patient with a conductance catheter'20158,706,219'Method and apparatus for monitoring an organ of a patient'20148,540,627'OCT using spectrally resolved bandwidth'20138,454,511'Magneto-motive ultrasound detection of magnetic nanoparticles'20138,162,834'Hemoglobin contrast in ultrasound and optical coherence tomography for diagnosing diseased tissue, cancers, and the like'20127,983,737'Optical coherence tomographic detection of cells and compositions'20117,983,736'Methods and compositions to reduce scattering of light during therapeutic and diagnostic imaging procedures'20117,925,335'Method and apparatus for determining cardiac performance in a patient with a conductance catheter'20117,853,316'Rotating optical catheter tip for optical coherence tomography'20107,801,590'Optical coherence tomographic detection of cells and killing of the same'20107,783,337'OCT using spectrally resolved bandwidth'20107,747,315'Methods and compositions to reduce scattering of light during therapeutic and diagnostic imaging procedures'20107,711,413'Catheter imaging probe and method'20107,238,199'Method and apparatus for stent deployment with enhanced delivery of bioactive agents'20076,494,832'Multifrequency conductance catheter-based system and method to determine LV function in a patient'20026,270,766'Anti-TNF antibodies and methotrexate in the treatment of arthritis and crohn\'s disease'20016,197,013'Method and apparatus for drug and gene delivery'20016,112,115'Method and apparatus for determining cardiac performance in a patient'20005,741,488'Treatment of rheumatoid arthritis with anti-CD4 antibodies in conjunction with anti-TNF antibodies'19985,009,634'Metabolic catheter'1991Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1998–2016Based in London, GB· patent location history
2000–2021Based in San Antonio, TX, US· patent location history
2001Based in Highgate, GB· patent location history
2007–2019Patents assigned to UNIV TEXAS (28)· patent assignee history
2012–2019Patents assigned to FELDMAN MARC D (16)· patent assignee history
2012–2015Patents assigned to MILNER THOMAS E (6)· patent assignee history
2012–2017Based in Austin, TX, US· patent location history
2014–2019Patents assigned to PEARCE JOHN A (10)· patent assignee history
2014–2019Patents assigned to VALVANO JONATHAN W (10)· patent assignee history
2020Based in Woodland Hills, CA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| UNIV TEXAS | 28 | 2007–2019 |
| FELDMAN MARC Dself | 16 | 2012–2019 |
| PEARCE JOHN A | 10 | 2014–2019 |
| VALVANO JONATHAN W | 10 | 2014–2019 |
| MILNER THOMAS E | 6 | 2012–2015 |
Locations
| Location | Patents | Span |
|---|---|---|
| San Antonio, Texas, US | 32 | 2000–2021 |
| Austin, Texas, US | 4 | 2012–2017 |
| London, GB | 2 | 1998–2016 |
| Woodland Hills, California, US | 1 | 2020 |
| Highgate, GB | 1 | 2001 |